1. Mucormycosis in COVID-19
- Author
-
Vasantha Kamath, Manimegalai Mathivanan, R B Vinay, and B Nivea
- Subjects
covid-19 ,diabetes ,mucormycosis ,steroids ,Internal medicine ,RC31-1245 - Abstract
Mucormycosis has emerged as a disease of immense importance, especially owing to the surge of cases during the second wave of COVID pandemic. Various factors are being attributed to the sudden burst of cases in our country, such as higher fungal spore counts in tropical climate, uncontrolled diabetes mellitus, prolonged steroid therapy, contamination of oxygen facilities, respiratory equipment, reused face mask, and zinc supplements. The need of the hour is to emphasize on awareness of early warning signs, as the benefits appear to be time sensitive.
- Published
- 2021
- Full Text
- View/download PDF